
Why You Should Update Your Clinical Trial Disclosure Policy for the EU Clinical Trials Regulation and ICMJE Requirements Now
By Karim Ibazatene, Associate Director, Transparency
Experts at MMS share their insights on trending topics in the pharmaceutical industry.